Literature DB >> 19528534

The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells.

Karin Wahlberg1, Jie Jiang, Helen Rooks, Kiran Jawaid, Fumihiko Matsuda, Masao Yamaguchi, Mark Lathrop, Swee Lay Thein, Steve Best.   

Abstract

HBS1L-MYB intergenic polymorphism (HMIP) on chromosome 6q23 is associated with elevated fetal hemoglobin levels and has pleiotropic effects on several hematologic parameters. To investigate potential regulatory activity in the region, we have measured sensitivity of the sequences to DNase I cleavage that identified 3 tissue-specific DNase I hypersensitive sites in the core intergenic interval. Chromatin immunoprecipitation with microarray (ChIP-chip) analysis showed strong histone acetylation in a defined interval of 65 kb corresponding to the core HBS1L-MYB intergenic region in primary human erythroid cells but not in non-MYB-expressing HeLa cells. ChIP-chip analysis also identified several potential cis-regulatory elements as strong GATA-1 signals that coincided with the DNase I hypersensitive sites present in MYB-expressing erythroid cells. We suggest that HMIP contains regulatory sequences that could be important in hematopoiesis by controlling MYB expression. This study provides the functional link between genetic association of HMIP with control of fetal hemoglobin and other hematologic parameters. We also present a large-scale analysis of histone acetylation as well as RNA polymerase II and GATA-1 interactions on chromosome 6q, and alpha and beta globin gene loci. The data suggest that GATA-1 regulates numerous genes of various functions on chromosome 6q.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528534     DOI: 10.1182/blood-2009-03-210146

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

2.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 3.  Transcriptional mechanisms underlying hemoglobin synthesis.

Authors:  Koichi R Katsumura; Andrew W DeVilbiss; Nathaniel J Pope; Kirby D Johnson; Emery H Bresnick
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

4.  A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.

Authors:  Khader Shameer; Joshua C Denny; Keyue Ding; Hayan Jouni; David R Crosslin; Mariza de Andrade; Christopher G Chute; Peggy Peissig; Jennifer A Pacheco; Rongling Li; Lisa Bastarache; Abel N Kho; Marylyn D Ritchie; Daniel R Masys; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Dan M Roden; Gail P Jarvik; Iftikhar J Kullo
Journal:  Hum Genet       Date:  2013-09-12       Impact factor: 4.132

5.  Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia.

Authors:  Sophia E Maharry; Christopher J Walker; Sandya Liyanarachchi; Sujay Mehta; Mitra Patel; Maryam A Bainazar; Xiaomeng Huang; Malori A Lankenau; Kevin W Hoag; Parvathi Ranganathan; Ramiro Garzon; James S Blachly; Denis C Guttridge; Clara D Bloomfield; Albert de la Chapelle; Ann-Kathrin Eisfeld
Journal:  Cancer Discov       Date:  2016-06-27       Impact factor: 39.397

6.  Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.

Authors:  Nadia Solovieff; Jacqueline N Milton; Stephen W Hartley; Richard Sherva; Paola Sebastiani; Daniel A Dworkis; Elizabeth S Klings; Lindsay A Farrer; Melanie E Garrett; Allison Ashley-Koch; Marilyn J Telen; Supan Fucharoen; Shau Yin Ha; Chi-Kong Li; David H K Chui; Clinton T Baldwin; Martin H Steinberg
Journal:  Blood       Date:  2009-12-16       Impact factor: 22.113

Review 7.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 8.  Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Authors:  Andrew Wilber; Arthur W Nienhuis; Derek A Persons
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

9.  A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.

Authors:  John J Farrell; Richard M Sherva; Zhi-Yi Chen; Hong-Yuan Luo; Benjamin F Chu; Shau Yin Ha; Chi Kong Li; Anselm C W Lee; Rever C H Li; Chi Keung Li; Hui Leung Yuen; Jason C C So; Edmond S K Ma; Li Chong Chan; Vivian Chan; Paola Sebastiani; Lindsay A Farrer; Clinton T Baldwin; Martin H Steinberg; David H K Chui
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

10.  Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.

Authors:  Mikiko Suzuki; Hiromi Yamazaki; Harumi Y Mukai; Hozumi Motohashi; Lihong Shi; Osamu Tanabe; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.